SI2373310T1 - Nove spojine 4- (heterocikloalkil) benzen-1, 3- diola kot inhibitorji tirosinaze, postopek njihove priprave in njihova uporaba v humani medicini in tudi v kozmetiki - Google Patents
Nove spojine 4- (heterocikloalkil) benzen-1, 3- diola kot inhibitorji tirosinaze, postopek njihove priprave in njihova uporaba v humani medicini in tudi v kozmetikiInfo
- Publication number
- SI2373310T1 SI2373310T1 SI200930399T SI200930399T SI2373310T1 SI 2373310 T1 SI2373310 T1 SI 2373310T1 SI 200930399 T SI200930399 T SI 200930399T SI 200930399 T SI200930399 T SI 200930399T SI 2373310 T1 SI2373310 T1 SI 2373310T1
- Authority
- SI
- Slovenia
- Prior art keywords
- heterocycloalkyl
- cosmetics
- benzene
- novel
- preparation
- Prior art date
Links
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 title 1
- 102000003425 Tyrosinase Human genes 0.000 title 1
- 108060008724 Tyrosinase Proteins 0.000 title 1
- 239000002537 cosmetic Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0858206A FR2939136B1 (fr) | 2008-12-02 | 2008-12-02 | Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
| US20212809P | 2009-01-30 | 2009-01-30 | |
| PCT/EP2009/066267 WO2010063773A1 (en) | 2008-12-02 | 2009-12-02 | Novel 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics |
| EP09796990A EP2373310B1 (en) | 2008-12-02 | 2009-12-02 | Novel 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2373310T1 true SI2373310T1 (sl) | 2013-01-31 |
Family
ID=40845880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200930399T SI2373310T1 (sl) | 2008-12-02 | 2009-12-02 | Nove spojine 4- (heterocikloalkil) benzen-1, 3- diola kot inhibitorji tirosinaze, postopek njihove priprave in njihova uporaba v humani medicini in tudi v kozmetiki |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8372879B2 (sl) |
| EP (2) | EP2373310B1 (sl) |
| JP (1) | JP5395188B2 (sl) |
| KR (1) | KR101290504B1 (sl) |
| CN (1) | CN102238948B (sl) |
| AR (1) | AR074454A1 (sl) |
| AU (1) | AU2009324080B2 (sl) |
| BR (1) | BRPI0916504B8 (sl) |
| CA (1) | CA2742703C (sl) |
| DK (1) | DK2373310T3 (sl) |
| ES (2) | ES2393916T3 (sl) |
| FR (1) | FR2939136B1 (sl) |
| HR (1) | HRP20120954T1 (sl) |
| MX (1) | MX2011005479A (sl) |
| PL (2) | PL2529735T3 (sl) |
| PT (1) | PT2373310E (sl) |
| RU (1) | RU2482116C2 (sl) |
| SI (1) | SI2373310T1 (sl) |
| SM (1) | SMT201200057B (sl) |
| WO (1) | WO2010063773A1 (sl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2939135B1 (fr) * | 2008-12-02 | 2010-12-03 | Galderma Res & Dev | Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
| HUE032948T2 (en) | 2011-03-23 | 2017-11-28 | Trevena Inc | Opioid receptor ligands and methods for their use and production |
| ES2635290T3 (es) | 2013-02-14 | 2017-10-03 | Galderma Research & Development | Procedimiento de síntesis de compuestos 4-(heterocicloalquil)-benceno-1,3-diol |
| WO2014139080A1 (en) * | 2013-03-12 | 2014-09-18 | Boehringer Ingelheim International Trading (Shanghai) Co., Ltd. | Novel process for the manufacture of 3-oxo-tetrahydrofuran |
| FR3030250B1 (fr) * | 2014-12-22 | 2018-11-02 | L'oreal | Composition aqueuse comprenant un compose 4-(heterocycloalkyl)-benzene-1,3-diol et un hydrotrope |
| FR3030251B1 (fr) * | 2014-12-22 | 2018-11-02 | L'oreal | Composition comprenant un compose 4-(heterocycloalkyl)-benzene-1,3-diol et un solvant particulier |
| FR3030252B1 (fr) * | 2014-12-22 | 2018-11-02 | L'oreal | Composition aqueuse comprenant un compose 4-(heterocycloalkyl)-benzene-1,3-diol, un monoalcool en c2-c4 et un glycol |
| FR3030249B1 (fr) * | 2014-12-22 | 2018-11-02 | L'oreal | Composition aqueuse comprenant un compose 4-(heterocycloalkyl)-benzene-1,3-diol, un polymere et un glycol |
| JP6873598B2 (ja) * | 2015-12-22 | 2021-05-19 | ロレアル | 活性成分のための改善された局所送達系 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0651619B2 (ja) | 1988-05-09 | 1994-07-06 | 株式会社クラレ | 美白剤 |
| FR2704428B1 (fr) | 1993-04-29 | 1995-06-09 | Oreal | Utilisation de dérivés de la résorcine substitués en position(s) 4, 4 et 5 ou 4 et 6 dans des compositions cosmétiques ou dermopharmaceutiques à action dépigmentante. |
| US6068834A (en) * | 1994-03-04 | 2000-05-30 | The Procter & Gamble Company | Skin lightening compositions |
| BR9803596A (pt) * | 1997-09-23 | 2000-04-25 | Pfizer Prod Inc | Derivados do resorcinol. |
| JPH11255637A (ja) * | 1998-03-13 | 1999-09-21 | Kansai Kouso Kk | チロシナーゼ活性阻害剤及び化粧料 |
| HN2000000033A (es) * | 1999-03-22 | 2001-02-02 | Pfizer Prod Inc | Composicion de resorcinol |
| WO2002020434A1 (en) * | 2000-09-07 | 2002-03-14 | Wisconsin Alumni Research Foundation | Synthesis of 17f labeled fluoroalkanes |
| DE60106954T2 (de) * | 2000-09-11 | 2005-12-01 | Pfizer Products Inc., Groton | Resorcin-derivate |
| US6852310B2 (en) | 2002-08-23 | 2005-02-08 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Skin lightening agents, compositions and methods |
| US6875425B2 (en) * | 2002-12-12 | 2005-04-05 | Unilever Home & Personal Care Usa | Skin lightening agents, compositions and methods |
| US7300646B2 (en) | 2004-02-27 | 2007-11-27 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Skin lightening agents, compositions and methods |
| US20060210497A1 (en) | 2005-03-18 | 2006-09-21 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Novel resorcinol derivatives |
| US20060210498A1 (en) | 2005-03-18 | 2006-09-21 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Novel resorcinol derivatives for skin |
| FR2917087B1 (fr) * | 2007-06-05 | 2012-09-21 | Galderma Res & Dev | Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique. |
-
2008
- 2008-12-02 FR FR0858206A patent/FR2939136B1/fr not_active Expired - Fee Related
-
2009
- 2009-12-02 KR KR1020117015284A patent/KR101290504B1/ko active IP Right Grant
- 2009-12-02 JP JP2011538010A patent/JP5395188B2/ja not_active Expired - Fee Related
- 2009-12-02 SI SI200930399T patent/SI2373310T1/sl unknown
- 2009-12-02 PT PT97969901T patent/PT2373310E/pt unknown
- 2009-12-02 AR ARP090104649A patent/AR074454A1/es unknown
- 2009-12-02 PL PL12182351T patent/PL2529735T3/pl unknown
- 2009-12-02 RU RU2011127120/04A patent/RU2482116C2/ru active
- 2009-12-02 EP EP09796990A patent/EP2373310B1/en active Active
- 2009-12-02 ES ES09796990T patent/ES2393916T3/es active Active
- 2009-12-02 MX MX2011005479A patent/MX2011005479A/es active IP Right Grant
- 2009-12-02 PL PL09796990T patent/PL2373310T3/pl unknown
- 2009-12-02 ES ES12182351.2T patent/ES2506265T3/es active Active
- 2009-12-02 DK DK09796990.1T patent/DK2373310T3/da active
- 2009-12-02 AU AU2009324080A patent/AU2009324080B2/en not_active Ceased
- 2009-12-02 BR BRPI0916504A patent/BRPI0916504B8/pt not_active IP Right Cessation
- 2009-12-02 US US13/131,161 patent/US8372879B2/en active Active
- 2009-12-02 EP EP12182351.2A patent/EP2529735B1/en not_active Not-in-force
- 2009-12-02 WO PCT/EP2009/066267 patent/WO2010063773A1/en active Application Filing
- 2009-12-02 CA CA2742703A patent/CA2742703C/en active Active
- 2009-12-02 CN CN200980148286.5A patent/CN102238948B/zh not_active Expired - Fee Related
-
2012
- 2012-11-21 HR HRP20120954AT patent/HRP20120954T1/hr unknown
- 2012-11-30 SM SM201200057T patent/SMT201200057B/it unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2373310T3 (pl) | Nowe związki 4-(heterocykloalkilo)benzeno-1,3-diolu jako inhibitory tyrozynazy, sposób ich otrzymywania oraz zastosowanie w medycynie i w kosmetykach | |
| IL225198A (en) | Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes | |
| IL234166B (en) | Isoindoline compounds, a pharmaceutical composition containing it and its use in the preparation of a medicine | |
| IL213259A0 (en) | Composition for the use to treat alzheimer's disease | |
| WO2014062733A3 (en) | Substituted benzene compounds | |
| IL205742A (en) | 4 - (4-Cyano-2-Theoaryl) dihydropyrimidinones, their preparation processes, medications containing them and their use | |
| WO2011060049A3 (en) | Spiro-oxindole mdm2 antagonists | |
| MX2012007098A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. | |
| MX2012007161A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. | |
| EP2170096A4 (en) | KERATIN HYDROLYSATES, PROCESS FOR THEIR PRODUCTION AND COSMETIC COMPOSITION CONTAINING SAME | |
| IL207546A0 (en) | Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases | |
| IL206562A0 (en) | Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition | |
| IT1391866B1 (it) | Composizione iniettabile di polinucleotidi per il trattamento di patologie osteoarticolari. | |
| BRPI0717766A2 (pt) | Processo para preparar composições contendo polifenol, composição, produto alimentício, medicamento, e, produto cosmético | |
| WO2009099553A3 (en) | Use of kinase inhibitor in treatment of atherosclerosis | |
| WO2009024374A3 (de) | Neue zwitterionische verbindungen enthaltende formulierungen und deren verwendung | |
| EP2343065A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING FELULIC ACID AND MATRINE COMPOUNDS, PREPARATION AND USE THEREOF | |
| EP2404591A4 (en) | COSMETIC PREPARATION, METHOD FOR THE PRODUCTION THEREOF, COMPOSITION FOR COSMETICS PREPARATIONS, METHOD FOR THE PRODUCTION THEREOF, COSMETIC PREPARATION WITH THE COMPOSITION FOR COSMETICS PREPARATIONS AND METHOD FOR THE PRODUCTION THEREOF, AND CLEANERS FOR INDUSTRIAL USE | |
| WO2008107092A3 (en) | Use of derivatives of 4-hydroxyphenoxy acetic acid | |
| IL215840A (en) | Arylsulfonamide compounds are converted into two positions 2 and 5, their pharmaceutical composition containing them and their use in the treatment of ccr3-related diseases | |
| GB2479251B (en) | Cosmetic or pharmaceutical composition, in particular intended for care or for makeup | |
| EP2285215A4 (en) | NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREFOR AND METHOD OF USE THEREOF | |
| GB0822486D0 (en) | Compounds for use in the treatment of pain | |
| WO2006103119A3 (en) | Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics | |
| MX2009012712A (es) | Nuevas 4-fenil-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica. |